ArticleJournal of thoracic disease2026
Feasibility and acceptability of a smart healthcare cloud platform based on a standardized discourse form in the postoperative follow-up of patients with non-small cell lung cancer.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Smart healthcare systems and cloud platforms have been widely used in the field of medicine and healthcare, but it is rarely being applied in the field of postoperative follow-up. This study aimed to assess the feasibility and acceptability of a smart healthcare cloud platform based on a standardized discourse form in the postoperative follow-up of patients with non-small cell lung cancer (NSCLC). Methods: A smart healthcare cloud platform was established by designing a standardized discourse form, and constructing a follow-up database and a health education platform. A total of 608 postoperative patients with NSCLC treated between June 2021 and June 2022 were enrolled in the study, including 306 patients in the intervention group and 302 patients in the control group. The patients in the intervention and control groups were followed up by the cloud platform and outpatient department, respectively. At the end of the follow-up period, a satisfaction follow-up survey and the Short-Form (SF)-36 Health Survey were administered. Results: There were no statistically significant differences in the baseline characteristics of the patients between the two groups. After 12 months of follow-up, 74.5%, 24.2%, 1.3% and 0.0% of patients in the intervention group were "strongly satisfied", "satisfied", "unsatisfied", and "strongly unsatisfied", respectively, compared with 61.3%, 35.1%, 2.6%, and 1.0% of patients in the control group (P<0.001). The intervention group showed similar results to the control group across the SF-36 Health Survey domain scores (average: 67.79±13.99 Conclusions: The smart healthcare cloud platform based on a standardized discourse form can achieve positive satisfaction of patients with follow-up and does not affect the quality of life of patients. Thus, its application is feasible and acceptable in the postoperative follow-up of patients with NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.